该文探讨二十碳五烯酸、二十二碳六烯酸联合麦芽糊精(maltodextrin,MED)膳食补充对Ⅱ型糖尿病大鼠肠道菌群、血液有机酸及脏器脂分布的影响。构建大鼠Ⅱ型糖尿病模型,以不同剂量MED灌胃患病大鼠,观察其对患病大鼠血糖水平、脏器指数及脏器脂类蓄积的影响,收集实验大鼠血液和粪便,利用高效液相色谱法检测大鼠血液的有机酸含量,通过16S rDNA扩增子测序获取各实验组肠道菌群的信息数据。MED灌胃尤其中剂量对糖尿病引起的多饮症状有一定的缓解作用,对于糖尿病导致的大鼠各器官脏器系数的增大有较好的改善趋势,但会引起脂类在心肝脾肺肾中的蓄积。对于糖尿病引起的肠道菌群的改变,中剂量MED有恢复某些优势有益菌群的相对丰度的趋势。MED可在一定趋势上缓解糖尿病引起的血液有机酸(如丙酸、丁酸、异戊酸和正戊酸)的变化。MED对Ⅱ型糖尿病引起的多饮、高血糖、脏器系数以及肠道菌群的改变有一定缓解作用,但会引起脂类在各脏器的蓄积,应谨慎使用。
The effects of eicosapentaenoic acid(EPA) and docosahexaenoic acid(DHA) combined with maltodextrin (MED) dietary on the gut flora, blood organic acids and visceral distribution of lipids in type Ⅱ diabetic rats were investigated. SD rat diabetes model was established by intraperitoneal administration of streptozotocin and oral administration of different doses of MED. The fasting blood glucose, visceral coefficient and lipid visceral distribution were detected. The blood and feces of the subject rats were collected for the blood organic acid detection (by HPLC), and for 16S rDNA amplicon sequencing analysis to obtain the information of intestinal flora in diabetic rat. The results showed that MED gavage, especially in middle dosage, had a certain alleviation effect on polydipsia and the augment of organ coefficient induced by diabetes mellitus but would cause lipids accumulation in solid organs. For the changes of intestinal flora induced by diabetes, middle-dose MED tended to restore the relative abundance of some dominant beneficial flora. MED could in some extent alleviate the diabetes-triggered alteration of blood organic acids as propionic acid, butanoic acid, isopentanoic acid and n-pentanoic acid. MED could alleviate the alteration of polydipsia, hyperglycemia, organ coefficient and intestinal flora caused by type Ⅱ diabetes (no statistical significance), but would induce lipids accumulation in visceral organs, Hence, it should be applied with caution.
[1] 刘柳. 二甲双胍联合胰岛素泵强化治疗2型糖尿病合并代谢综合征40例[J].临床荟萃, 2014, 29(9):1 047-1 050.
LIU L.Metformin combined with insulin pump for intensive treatment of 40 cases of type 2 diabetes mellitus complicated with metabolic syndrome[J].Clinical Focus, 2014, 29(9):1 047-1 050.
[2] 王锋, 杨立刚, 孙桂菊.ω-3多不饱和脂肪酸对Ⅱ型糖尿病患者糖脂代谢的影响[J].食品安全质量检测学报, 2015, 6(10):3 907-3 910.
WANG F, YANG L G, SUN G J.Effect of ω-3 polyunsaturated fatty acids on glucose and lipid metabolism in patients with type 2 diabetes[J].Journal of Food Safety and Quality, 2015, 6(10):3 907-3 910.
[3] ANNUZZI G, RIVELLESE A, CAPALDO B, et al.A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients[J].Atherosclerosis, 1991, 87(1):65-73.
[4] FRIEDBERG C E, JANSSEN M J, HEINE R J, et al.Fish oil and glycemic control in diabetes.A meta-analysis[J].Diabetes Care, 1998, 21(4):494-500.
[5] MONTORI V M, FARMER A, WOLLAN P C, et al.Fish oil supplementation in type 2 diabetes:A quantitative systematic review[J].Diabetes Care, 2000, 23(9):1 407-1 415.
[6] MOSTAD I L, BJERVE K S, BJORGAAS M R, et al.Effects of n-3 fatty acids in subjects with type 2 diabetes:Reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation[J].The American Journal of Clinical Nutrition, 2006, 84(3):540-550.
[7] ASTINA J, SAPWAROBOL S.Resistant maltodextrin and metabolic syndrome:A review[J].Journal of the American College of Nutrition, 2019, 38(4):380-385.
[8] LI S G, GUERIN-DEREMAUX L, POCHAT M, et al.NUTRIOSE dietary fiber supplementation improves insulin resistance and determinants of metabolic syndrome in over weight men:A double-blind, randomized, placebo-controlled study[J].Applied Physiology, Nutrition, and Metabolism, 2010, 35(6):773-782.
[9] ALIASGHARZADEH A, DEHGHAN P, GARGARI B P, et al.Resistant dextrin, as a prebiotic, improves insulin resistance and inflammation in women with type 2 diabetes:A randomised controlled clinical trial[J].The British Journal of Nutrition, 2015, 113(2):321-330.
[10] BAER D J, STOTE K S, HENDERSON T, et al.The metabolizable energy of dietary resistant maltodextrin is variable and alters fecal microbiota composition in adult men-3[J].The Journal of Nutrition, 2014, 144(7):1 023-1 029.
[11] 崔祥, 陶金华, 江曙, 等.肠道菌群与Ⅱ型糖尿病相关性的研究进展[J].中国微生态学杂志, 2017, 29(11):1 346-1 349.
CUI X, TAO J H, JIANG S, et al. Research progress of relationship of gut microbiota and type 2 diabetes mellitus[J]. Chinese Journal of Microecology, 2017, 29(11):1 346-1 349.
[12] FLINT H J, SCOTT K P, LOUIS P, et al.The role of the gut microbiota in nutrition and health[J].Nature Reviews Gastroenterology & Hepatology, 2012, 9(10):577-589.
[13] KUMAR M, PAL N, SHARMA P, et al.Omega-3 fatty acids and their interaction with the gut microbiome in the prevention and amelioration of type-2 diabetes[J].Nutrients, 2022, 14(9):1723.
[14] 克迎迎. 基于蛋白组学技术研究卷柏总黄酮及穗花杉双黄酮降糖作用机制[D].郑州:河南中医学院, 2014.
KE Y Y.The research of total flavonoids of Selaginella tamariscina (Beauv.) spring and amentoflavone on improving insulin resistance by the method of proteomics[D].Zhengzhou:Henan College of Chinese Medicine, 2014.
[15] 康黎, 邹勇, 李宏增, 等.二十碳五烯酸在糖尿病心肌病损伤中的作用及机制[J].心脏杂志, 2019, 31(5):521-525.
KANG L, ZOU Y, LI H Z, et al.Role and mechanism of eicosapentaenoic acid in cardiac injury of diabetic cardiomyopathy[J].Chinese Heart Journal, 2019, 31(5):521-525.
[16] 张敏芳, 钱家麒, TOMINO YASUHIKO.二十碳五烯酸对早期糖尿病肾病小鼠炎症和氧化应激状态的作用[J].中国中西医结合肾病杂志, 2008, 9(8):668-670;754.
ZHANG M F, QIAN J Q, TOMINO Y.Effects of eicosapentaenoic acid on the inflammation and oxidative stress during the early stage of diabetic nephropathy in KKAy/Ta mice[J].Chinese Journal of Integrated Traditional and Western Nephrology, 2008, 9(8):668-670;754.
[17] 胡传水. 2型糖尿病患者血脂水平分析[J].医学检验与临床, 2008, 19(1):55-56.
HU C S.Analysis of blood-lipid level on type 2 diabetes mellitus[J].Medical Laboratory Science and Clinics, 2008, 19(1):55-56.
[18] GRICE E A, KONG H H, CONLAN S, et al.Topographical and temporal diversity of the human skin microbiome[J].Science, 2009, 324(5 931):1 190-1 192.
[19] 于斌, 王敏, 李丹, 等.Ⅱ型糖尿病痰湿热互结证患者肠道菌群特征分析[J].世界中西医结合杂志, 2020, 15(11):2 102-2 107;2 111.
YU B, WANG M, LI D, et al.Analysis the characteristics of intestinal flora characteristics on T2DM with phlegm-dampness-heat syndrome[J].World Journal of Integrated Traditional and Western Medicine, 2020, 15(11):2 102-2 107;2 111.
[20] 李彩凤.Ⅱ型糖尿病胰岛素抵抗患者肠道菌群变化及与炎症因子水平的关系[J].现代实用医学, 2021, 33(5):670-671.
LI C F. Changes of intestinal flora and its relationship with inflammatory factors in patients with type 2 diabetes mellitus and insulin resistance[J]. Modern Practical Medicine, 2021, 33(5):670-671.
[21] ANDREASEN A S, LARSEN N, PEDERSEN-SKOVSGAARD T, et al.Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects[J].The British Journal of Nutrition, 2010, 104(12):1 831-1 838.
